253 related articles for article (PubMed ID: 24909153)
1. Ontology-supported research on vaccine efficacy, safety and integrative biological networks.
He Y
Expert Rev Vaccines; 2014 Jul; 13(7):825-41. PubMed ID: 24909153
[TBL] [Abstract][Full Text] [Related]
2. Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research.
He Y
Curr Pharmacol Rep; 2016 Jun; 2(3):113-128. PubMed ID: 27458549
[TBL] [Abstract][Full Text] [Related]
3. Ontology-Based Vaccine Adverse Event Representation and Analysis.
Xie J; He Y
Adv Exp Med Biol; 2017; 1028():89-103. PubMed ID: 29058218
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal vaccines.
Price AA
Curr Pharm Des; 2007; 13(19):2009-14. PubMed ID: 17627534
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Failure After Meningococcal C Conjugate Vaccine May Be Linked to Decline of Bactericidal Titers and Absence of Herd Immunity.
Matar R; Hong E; Levy C; Guillot M; Cohen R; Taha MK; Madhi F
Pediatr Infect Dis J; 2015 Oct; 34(10):1142-3. PubMed ID: 26367811
[No Abstract] [Full Text] [Related]
6. Authors' response: Meningococcal vaccine antigen diversity in global databases.
Brehony C; Hill DM; Lucidarme J; Borrow R; Maiden MC
Euro Surveill; 2016 Apr; 21(15):. PubMed ID: 27104935
[No Abstract] [Full Text] [Related]
7. Toward a meningitis-free world.
Black S; Pizza M; Nissum M; Rappuoli R
Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
[TBL] [Abstract][Full Text] [Related]
8. Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development.
Xie J; Zi W; Li Z; He Y
Curr Pharm Des; 2021; 27(7):900-910. PubMed ID: 33238868
[TBL] [Abstract][Full Text] [Related]
9. The Ontology of Biological and Clinical Statistics (OBCS) for standardized and reproducible statistical analysis.
Zheng J; Harris MR; Masci AM; Lin Y; Hero A; Smith B; He Y
J Biomed Semantics; 2016 Sep; 7(1):53. PubMed ID: 27627881
[TBL] [Abstract][Full Text] [Related]
10. A vaccine against meningitis in Africa.
Lancet Infect Dis; 2011 Jan; 11(1):1. PubMed ID: 21183138
[No Abstract] [Full Text] [Related]
11. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
Deeks ED
Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
[No Abstract] [Full Text] [Related]
12. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
Heyderman RS; Davenport V; Williams NA
Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
[TBL] [Abstract][Full Text] [Related]
13. MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults.
Tipton M; Daly W; Senders S; Block SL; Lattanzi M; Mzolo T; Barbi S; Pellegrini M; Keshavan P
Vaccine; 2019 Sep; 37(42):6171-6179. PubMed ID: 31495595
[TBL] [Abstract][Full Text] [Related]
14. Ontology-based literature mining of E. coli vaccine-associated gene interaction networks.
Hur J; Özgür A; He Y
J Biomed Semantics; 2017 Mar; 8(1):12. PubMed ID: 28288685
[TBL] [Abstract][Full Text] [Related]
15. Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.
Poellabauer EM; Pavlova BG; Fritsch S; Singer J; Neubauer C; Doralt J; Valenta-Singer B; Ehrlich HJ
Vaccine; 2013 Aug; 31(35):3611-6. PubMed ID: 23672977
[TBL] [Abstract][Full Text] [Related]
16. [Neisseria meningitidis: new vaccines and preventive strategies].
Morciano L; Zaratti L; Franco E
Ig Sanita Pubbl; 2012; 68(1):97-104. PubMed ID: 22507995
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for the prevention of meningococcal disease in children.
Soriano-Gabarró M; Stuart JM; Rosenstein NE
Semin Pediatr Infect Dis; 2002 Jul; 13(3):182-9. PubMed ID: 12199614
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy, safety, and cost-effectiveness of meningococcal vaccines].
Chinese Preventive Medicine Association
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):129-135. PubMed ID: 30744260
[TBL] [Abstract][Full Text] [Related]
19. Development of new vaccines against meningococcal disease.
Bröker M
Arzneimittelforschung; 2003; 53(12):805-13. PubMed ID: 14732960
[TBL] [Abstract][Full Text] [Related]
20. Prevention of meningococcal disease.
Woodard JL; Berman DM
Fetal Pediatr Pathol; 2006; 25(6):311-9. PubMed ID: 17696042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
